aluates Reports

$ 0.0

Automative

Global Neuromuscular Blocking Agent (NMBA) Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-31A7155

Global Neuromuscular Blocking Agent NMBA Market Insights and Forecast to 2028

BUY CHAPTERS

Global Neuromuscular Blocking Agent (NMBA) Market Insights, Forecast to 2030

Code: QYRE-Auto-31A7155

Report

December 2024

Pages:106

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

GlaxoSmithKline PLC

Pfizer Inc

Hengrui Pharmaceutical

Abbott Laboratories

Fresenius Kabi

Sandoz Inc

Somerset Therapeutics

Guike Pharmaceutical

Shanghai Pharmaceuticals

Themis Medicare

Nanjing King-friend

Neuromuscular Blocking Agent (NMBA) Market

The global Neuromuscular Blocking Agent (NMBA) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Neuromuscular Blocking Agent (NMBA) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Neuromuscular Blocking Agent (NMBA) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Neuromuscular Blocking Agent (NMBA) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Neuromuscular Blocking Agent (NMBA) include AbbVie, GlaxoSmithKline, Pfizer, Hengrui Pharmaceutical, Abbott Laboratories, Fresenius Kabi, Sandoz, Somerset Therapeutics and Guike Pharmaceutical, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Report Covers:

This report presents an overview of global market for Neuromuscular Blocking Agent (NMBA), sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Neuromuscular Blocking Agent (NMBA), also provides the sales of main regions and countries. Highlights of the upcoming market potential for Neuromuscular Blocking Agent (NMBA), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neuromuscular Blocking Agent (NMBA) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Neuromuscular Blocking Agent (NMBA) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Neuromuscular Blocking Agent (NMBA) sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Neuromuscular Blocking Agent (NMBA) Market Report

Report Metric	Details
Report Name	Neuromuscular Blocking Agent (NMBA) Market
Segment by Type	Depolarizing Non-depolarizing
Segment by Application	Hospital Clinic Pharmacy Others
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Hengrui Pharmaceutical, Abbott Laboratories, Fresenius Kabi, Sandoz, Somerset Therapeutics, Guike Pharmaceutical, Shanghai Pharmaceuticals, Themis Medicare, Nanjing King-Friend
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Neuromuscular Blocking Agent (NMBA) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Neuromuscular Blocking Agent (NMBA) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neuromuscular Blocking Agent (NMBA) sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Neuromuscular Blocking Agent (NMBA) Market report?

Ans: The main players in the Neuromuscular Blocking Agent (NMBA) Market are Pfizer, Hengrui Pharmaceutical, Abbott Laboratories, Fresenius Kabi, Sandoz, Somerset Therapeutics, Guike Pharmaceutical, Shanghai Pharmaceuticals, Themis Medicare, Nanjing King-Friend

What are the Application segmentation covered in the Neuromuscular Blocking Agent (NMBA) Market report?

Ans: The Applications covered in the Neuromuscular Blocking Agent (NMBA) Market report are Hospital, Clinic, Pharmacy, Others

What are the Type segmentation covered in the Neuromuscular Blocking Agent (NMBA) Market report?

Ans: The Types covered in the Neuromuscular Blocking Agent (NMBA) Market report are Depolarizing, Non-depolarizing

Recommended Reports

Muscle & Nerve Disorders

Neurodegenerative & Brain

Cardiac & Vascular Care

1 Study Coverage

1.1 Neuromuscular Blocking Agent (NMBA) Product Introduction

1.2 Market by Type

1.2.1 Global Neuromuscular Blocking Agent (NMBA) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Depolarizing

1.2.3 Non-depolarizing

1.3 Market by Application

1.3.1 Global Neuromuscular Blocking Agent (NMBA) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Pharmacy

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Neuromuscular Blocking Agent (NMBA) Sales Estimates and Forecasts 2019-2030

2.2 Global Neuromuscular Blocking Agent (NMBA) Revenue by Region

2.2.1 Global Neuromuscular Blocking Agent (NMBA) Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Neuromuscular Blocking Agent (NMBA) Revenue by Region (2019-2024)

2.2.3 Global Neuromuscular Blocking Agent (NMBA) Revenue by Region (2025-2030)

2.2.4 Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Region (2019-2030)

2.3 Global Neuromuscular Blocking Agent (NMBA) Sales Estimates and Forecasts 2019-2030

2.4 Global Neuromuscular Blocking Agent (NMBA) Sales by Region

2.4.1 Global Neuromuscular Blocking Agent (NMBA) Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Neuromuscular Blocking Agent (NMBA) Sales by Region (2019-2024)

2.4.3 Global Neuromuscular Blocking Agent (NMBA) Sales by Region (2025-2030)

2.4.4 Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Neuromuscular Blocking Agent (NMBA) Sales by Manufacturers

3.1.1 Global Neuromuscular Blocking Agent (NMBA) Sales by Manufacturers (2019-2024)

3.1.2 Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Neuromuscular Blocking Agent (NMBA) in 2023

3.2 Global Neuromuscular Blocking Agent (NMBA) Revenue by Manufacturers

3.2.1 Global Neuromuscular Blocking Agent (NMBA) Revenue by Manufacturers (2019-2024)

3.2.2 Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Neuromuscular Blocking Agent (NMBA) Revenue in 2023

3.3 Global Key Players of Neuromuscular Blocking Agent (NMBA), Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Neuromuscular Blocking Agent (NMBA) Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Neuromuscular Blocking Agent (NMBA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Neuromuscular Blocking Agent (NMBA), Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Neuromuscular Blocking Agent (NMBA), Product Offered and Application

3.8 Global Key Manufacturers of Neuromuscular Blocking Agent (NMBA), Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Neuromuscular Blocking Agent (NMBA) Sales by Type

4.1.1 Global Neuromuscular Blocking Agent (NMBA) Historical Sales by Type (2019-2024)

4.1.2 Global Neuromuscular Blocking Agent (NMBA) Forecasted Sales by Type (2025-2030)

4.1.3 Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2019-2030)

4.2 Global Neuromuscular Blocking Agent (NMBA) Revenue by Type

4.2.1 Global Neuromuscular Blocking Agent (NMBA) Historical Revenue by Type (2019-2024)

4.2.2 Global Neuromuscular Blocking Agent (NMBA) Forecasted Revenue by Type (2025-2030)

4.2.3 Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Type (2019-2030)

4.3 Global Neuromuscular Blocking Agent (NMBA) Price by Type

4.3.1 Global Neuromuscular Blocking Agent (NMBA) Price by Type (2019-2024)

4.3.2 Global Neuromuscular Blocking Agent (NMBA) Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Neuromuscular Blocking Agent (NMBA) Sales by Application

5.1.1 Global Neuromuscular Blocking Agent (NMBA) Historical Sales by Application (2019-2024)

5.1.2 Global Neuromuscular Blocking Agent (NMBA) Forecasted Sales by Application (2025-2030)

5.1.3 Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2019-2030)

5.2 Global Neuromuscular Blocking Agent (NMBA) Revenue by Application

5.2.1 Global Neuromuscular Blocking Agent (NMBA) Historical Revenue by Application (2019-2024)

5.2.2 Global Neuromuscular Blocking Agent (NMBA) Forecasted Revenue by Application (2025-2030)

5.2.3 Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Application (2019-2030)

5.3 Global Neuromuscular Blocking Agent (NMBA) Price by Application

5.3.1 Global Neuromuscular Blocking Agent (NMBA) Price by Application (2019-2024)

5.3.2 Global Neuromuscular Blocking Agent (NMBA) Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Neuromuscular Blocking Agent (NMBA) Market Size by Type

6.1.1 US & Canada Neuromuscular Blocking Agent (NMBA) Sales by Type (2019-2030)

6.1.2 US & Canada Neuromuscular Blocking Agent (NMBA) Revenue by Type (2019-2030)

6.2 US & Canada Neuromuscular Blocking Agent (NMBA) Market Size by Application

6.2.1 US & Canada Neuromuscular Blocking Agent (NMBA) Sales by Application (2019-2030)

6.2.2 US & Canada Neuromuscular Blocking Agent (NMBA) Revenue by Application (2019-2030)

6.3 US & Canada Neuromuscular Blocking Agent (NMBA) Market Size by Country

6.3.1 US & Canada Neuromuscular Blocking Agent (NMBA) Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Neuromuscular Blocking Agent (NMBA) Sales by Country (2019-2030)

6.3.3 US & Canada Neuromuscular Blocking Agent (NMBA) Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Neuromuscular Blocking Agent (NMBA) Market Size by Type

7.1.1 Europe Neuromuscular Blocking Agent (NMBA) Sales by Type (2019-2030)

7.1.2 Europe Neuromuscular Blocking Agent (NMBA) Revenue by Type (2019-2030)

7.2 Europe Neuromuscular Blocking Agent (NMBA) Market Size by Application

7.2.1 Europe Neuromuscular Blocking Agent (NMBA) Sales by Application (2019-2030)

7.2.2 Europe Neuromuscular Blocking Agent (NMBA) Revenue by Application (2019-2030)

7.3 Europe Neuromuscular Blocking Agent (NMBA) Market Size by Country

7.3.1 Europe Neuromuscular Blocking Agent (NMBA) Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Neuromuscular Blocking Agent (NMBA) Sales by Country (2019-2030)

7.3.3 Europe Neuromuscular Blocking Agent (NMBA) Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Neuromuscular Blocking Agent (NMBA) Market Size

8.1.1 China Neuromuscular Blocking Agent (NMBA) Sales (2019-2030)

8.1.2 China Neuromuscular Blocking Agent (NMBA) Revenue (2019-2030)

8.2 China Neuromuscular Blocking Agent (NMBA) Market Size by Application

8.2.1 China Neuromuscular Blocking Agent (NMBA) Sales by Application (2019-2030)

8.2.2 China Neuromuscular Blocking Agent (NMBA) Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Neuromuscular Blocking Agent (NMBA) Market Size by Type

9.1.1 Asia Neuromuscular Blocking Agent (NMBA) Sales by Type (2019-2030)

9.1.2 Asia Neuromuscular Blocking Agent (NMBA) Revenue by Type (2019-2030)

9.2 Asia Neuromuscular Blocking Agent (NMBA) Market Size by Application

9.2.1 Asia Neuromuscular Blocking Agent (NMBA) Sales by Application (2019-2030)

9.2.2 Asia Neuromuscular Blocking Agent (NMBA) Revenue by Application (2019-2030)

9.3 Asia Neuromuscular Blocking Agent (NMBA) Sales by Region

9.3.1 Asia Neuromuscular Blocking Agent (NMBA) Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Neuromuscular Blocking Agent (NMBA) Revenue by Region (2019-2030)

9.3.3 Asia Neuromuscular Blocking Agent (NMBA) Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Market Size by Type

10.1.1 Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Market Size by Application

10.2.1 Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Sales by Country

10.3.1 Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 AbbVie

11.1.1 AbbVie Company Information

11.1.2 AbbVie Overview

11.1.3 AbbVie Neuromuscular Blocking Agent (NMBA) Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 AbbVie Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 AbbVie Recent Developments

11.2 GlaxoSmithKline

11.2.1 GlaxoSmithKline Company Information

11.2.2 GlaxoSmithKline Overview

11.2.3 GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 GlaxoSmithKline Recent Developments

11.3 Pfizer

11.3.1 Pfizer Company Information

11.3.2 Pfizer Overview

11.3.3 Pfizer Neuromuscular Blocking Agent (NMBA) Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Pfizer Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Pfizer Recent Developments

11.4 Hengrui Pharmaceutical

11.4.1 Hengrui Pharmaceutical Company Information

11.4.2 Hengrui Pharmaceutical Overview

11.4.3 Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Hengrui Pharmaceutical Recent Developments

11.5 Abbott Laboratories

11.5.1 Abbott Laboratories Company Information

11.5.2 Abbott Laboratories Overview

11.5.3 Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Abbott Laboratories Recent Developments

11.6 Fresenius Kabi

11.6.1 Fresenius Kabi Company Information

11.6.2 Fresenius Kabi Overview

11.6.3 Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Fresenius Kabi Recent Developments

11.7 Sandoz

11.7.1 Sandoz Company Information

11.7.2 Sandoz Overview

11.7.3 Sandoz Neuromuscular Blocking Agent (NMBA) Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Sandoz Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Sandoz Recent Developments

11.8 Somerset Therapeutics

11.8.1 Somerset Therapeutics Company Information

11.8.2 Somerset Therapeutics Overview

11.8.3 Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Somerset Therapeutics Recent Developments

11.9 Guike Pharmaceutical

11.9.1 Guike Pharmaceutical Company Information

11.9.2 Guike Pharmaceutical Overview

11.9.3 Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Guike Pharmaceutical Recent Developments

11.10 Shanghai Pharmaceuticals

11.10.1 Shanghai Pharmaceuticals Company Information

11.10.2 Shanghai Pharmaceuticals Overview

11.10.3 Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Shanghai Pharmaceuticals Recent Developments

11.11 Themis Medicare

11.11.1 Themis Medicare Company Information

11.11.2 Themis Medicare Overview

11.11.3 Themis Medicare Neuromuscular Blocking Agent (NMBA) Sales, Price, Revenue and Gross Margin (2019-2024)

11.11.4 Themis Medicare Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Themis Medicare Recent Developments

11.12 Nanjing King-Friend

11.12.1 Nanjing King-Friend Company Information

11.12.2 Nanjing King-Friend Overview

11.12.3 Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Sales, Price, Revenue and Gross Margin (2019-2024)

11.12.4 Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Nanjing King-Friend Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Neuromuscular Blocking Agent (NMBA) Industry Chain Analysis

12.2 Neuromuscular Blocking Agent (NMBA) Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Neuromuscular Blocking Agent (NMBA) Production Mode & Process

12.4 Neuromuscular Blocking Agent (NMBA) Sales and Marketing

12.4.1 Neuromuscular Blocking Agent (NMBA) Sales Channels

12.4.2 Neuromuscular Blocking Agent (NMBA) Distributors

12.5 Neuromuscular Blocking Agent (NMBA) Customers

13 Market Dynamics

13.1 Neuromuscular Blocking Agent (NMBA) Industry Trends

13.2 Neuromuscular Blocking Agent (NMBA) Market Drivers

13.3 Neuromuscular Blocking Agent (NMBA) Market Challenges

13.4 Neuromuscular Blocking Agent (NMBA) Market Restraints

14 Key Findings in The Global Neuromuscular Blocking Agent (NMBA) Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

AbbVie

GlaxoSmithKline PLC

Pfizer Inc

Hengrui Pharmaceutical

Abbott Laboratories

Fresenius Kabi

Sandoz Inc

Somerset Therapeutics

Guike Pharmaceutical

Shanghai Pharmaceuticals

Themis Medicare

Nanjing King-friend

List of Tables

Table 1. Global Neuromuscular Blocking Agent (NMBA) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Depolarizing

Table 3. Major Manufacturers of Non-depolarizing

Table 4. Global Neuromuscular Blocking Agent (NMBA) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Neuromuscular Blocking Agent (NMBA) Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Neuromuscular Blocking Agent (NMBA) Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Neuromuscular Blocking Agent (NMBA) Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Region (2019-2024)

Table 9. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Region (2025-2030)

Table 10. Global Neuromuscular Blocking Agent (NMBA) Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Neuromuscular Blocking Agent (NMBA) Sales by Region (2019-2024) & (MT)

Table 12. Global Neuromuscular Blocking Agent (NMBA) Sales by Region (2025-2030) & (MT)

Table 13. Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Region (2019-2024)

Table 14. Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Region (2025-2030)

Table 15. Global Neuromuscular Blocking Agent (NMBA) Sales by Manufacturers (2019-2024) & (MT)

Table 16. Global Neuromuscular Blocking Agent (NMBA) Sales Share by Manufacturers (2019-2024)

Table 17. Global Neuromuscular Blocking Agent (NMBA) Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Neuromuscular Blocking Agent (NMBA) Revenue Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Neuromuscular Blocking Agent (NMBA), Industry Ranking, 2022 VS 2023 VS 2024

Table 20. Neuromuscular Blocking Agent (NMBA) Price by Manufacturers 2019-2024 (USD/MT)

Table 21. Global Neuromuscular Blocking Agent (NMBA) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Neuromuscular Blocking Agent (NMBA) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromuscular Blocking Agent (NMBA) as of 2023)

Table 23. Global Key Manufacturers of Neuromuscular Blocking Agent (NMBA), Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Neuromuscular Blocking Agent (NMBA), Product Offered and Application

Table 25. Global Key Manufacturers of Neuromuscular Blocking Agent (NMBA), Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Neuromuscular Blocking Agent (NMBA) Sales by Type (2019-2024) & (MT)

Table 28. Global Neuromuscular Blocking Agent (NMBA) Sales by Type (2025-2030) & (MT)

Table 29. Global Neuromuscular Blocking Agent (NMBA) Sales Share by Type (2019-2024)

Table 30. Global Neuromuscular Blocking Agent (NMBA) Sales Share by Type (2025-2030)

Table 31. Global Neuromuscular Blocking Agent (NMBA) Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Neuromuscular Blocking Agent (NMBA) Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Neuromuscular Blocking Agent (NMBA) Revenue Share by Type (2019-2024)

Table 34. Global Neuromuscular Blocking Agent (NMBA) Revenue Share by Type (2025-2030)

Table 35. Neuromuscular Blocking Agent (NMBA) Price by Type (2019-2024) & (USD/MT)

Table 36. Global Neuromuscular Blocking Agent (NMBA) Price Forecast by Type (2025-2030) & (USD/MT)

Table 37. Global Neuromuscular Blocking Agent (NMBA) Sales by Application (2019-2024) & (MT)

Table 38. Global Neuromuscular Blocking Agent (NMBA) Sales by Application (2025-2030) & (MT)

Table 39. Global Neuromuscular Blocking Agent (NMBA) Sales Share by Application (2019-2024)

Table 40. Global Neuromuscular Blocking Agent (NMBA) Sales Share by Application (2025-2030)

Table 41. Global Neuromuscular Blocking Agent (NMBA) Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Neuromuscular Blocking Agent (NMBA) Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Neuromuscular Blocking Agent (NMBA) Revenue Share by Application (2019-2024)

Table 44. Global Neuromuscular Blocking Agent (NMBA) Revenue Share by Application (2025-2030)

Table 45. Neuromuscular Blocking Agent (NMBA) Price by Application (2019-2024) & (USD/MT)

Table 46. Global Neuromuscular Blocking Agent (NMBA) Price Forecast by Application (2025-2030) & (USD/MT)

Table 47. US & Canada Neuromuscular Blocking Agent (NMBA) Sales by Type (2019-2024) & (MT)

Table 48. US & Canada Neuromuscular Blocking Agent (NMBA) Sales by Type (2025-2030) & (MT)

Table 49. US & Canada Neuromuscular Blocking Agent (NMBA) Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Neuromuscular Blocking Agent (NMBA) Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Neuromuscular Blocking Agent (NMBA) Sales by Application (2019-2024) & (MT)

Table 52. US & Canada Neuromuscular Blocking Agent (NMBA) Sales by Application (2025-2030) & (MT)

Table 53. US & Canada Neuromuscular Blocking Agent (NMBA) Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Neuromuscular Blocking Agent (NMBA) Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Neuromuscular Blocking Agent (NMBA) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Neuromuscular Blocking Agent (NMBA) Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Neuromuscular Blocking Agent (NMBA) Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Neuromuscular Blocking Agent (NMBA) Sales by Country (2019-2024) & (MT)

Table 59. US & Canada Neuromuscular Blocking Agent (NMBA) Sales by Country (2025-2030) & (MT)

Table 60. Europe Neuromuscular Blocking Agent (NMBA) Sales by Type (2019-2024) & (MT)

Table 61. Europe Neuromuscular Blocking Agent (NMBA) Sales by Type (2025-2030) & (MT)

Table 62. Europe Neuromuscular Blocking Agent (NMBA) Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Neuromuscular Blocking Agent (NMBA) Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Neuromuscular Blocking Agent (NMBA) Sales by Application (2019-2024) & (MT)

Table 65. Europe Neuromuscular Blocking Agent (NMBA) Sales by Application (2025-2030) & (MT)

Table 66. Europe Neuromuscular Blocking Agent (NMBA) Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Neuromuscular Blocking Agent (NMBA) Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Neuromuscular Blocking Agent (NMBA) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Neuromuscular Blocking Agent (NMBA) Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Neuromuscular Blocking Agent (NMBA) Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Neuromuscular Blocking Agent (NMBA) Sales by Country (2019-2024) & (MT)

Table 72. Europe Neuromuscular Blocking Agent (NMBA) Sales by Country (2025-2030) & (MT)

Table 73. China Neuromuscular Blocking Agent (NMBA) Sales by Type (2019-2024) & (MT)

Table 74. China Neuromuscular Blocking Agent (NMBA) Sales by Type (2025-2030) & (MT)

Table 75. China Neuromuscular Blocking Agent (NMBA) Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Neuromuscular Blocking Agent (NMBA) Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Neuromuscular Blocking Agent (NMBA) Sales by Application (2019-2024) & (MT)

Table 78. China Neuromuscular Blocking Agent (NMBA) Sales by Application (2025-2030) & (MT)

Table 79. China Neuromuscular Blocking Agent (NMBA) Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Neuromuscular Blocking Agent (NMBA) Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Neuromuscular Blocking Agent (NMBA) Sales by Type (2019-2024) & (MT)

Table 82. Asia Neuromuscular Blocking Agent (NMBA) Sales by Type (2025-2030) & (MT)

Table 83. Asia Neuromuscular Blocking Agent (NMBA) Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Neuromuscular Blocking Agent (NMBA) Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Neuromuscular Blocking Agent (NMBA) Sales by Application (2019-2024) & (MT)

Table 86. Asia Neuromuscular Blocking Agent (NMBA) Sales by Application (2025-2030) & (MT)

Table 87. Asia Neuromuscular Blocking Agent (NMBA) Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Neuromuscular Blocking Agent (NMBA) Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Neuromuscular Blocking Agent (NMBA) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Neuromuscular Blocking Agent (NMBA) Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Neuromuscular Blocking Agent (NMBA) Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Neuromuscular Blocking Agent (NMBA) Sales by Region (2019-2024) & (MT)

Table 93. Asia Neuromuscular Blocking Agent (NMBA) Sales by Region (2025-2030) & (MT)

Table 94. Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Sales by Type (2019-2024) & (MT)

Table 95. Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Sales by Type (2025-2030) & (MT)

Table 96. Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Sales by Application (2019-2024) & (MT)

Table 99. Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Sales by Application (2025-2030) & (MT)

Table 100. Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Sales by Country (2019-2024) & (MT)

Table 106. Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Sales by Country (2025-2030) & (MT)

Table 107. AbbVie Company Information

Table 108. AbbVie Description and Major Businesses

Table 109. AbbVie Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 110. AbbVie Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. AbbVie Recent Developments

Table 112. GlaxoSmithKline Company Information

Table 113. GlaxoSmithKline Description and Major Businesses

Table 114. GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 115. GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. GlaxoSmithKline Recent Developments

Table 117. Pfizer Company Information

Table 118. Pfizer Description and Major Businesses

Table 119. Pfizer Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 120. Pfizer Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Pfizer Recent Developments

Table 122. Hengrui Pharmaceutical Company Information

Table 123. Hengrui Pharmaceutical Description and Major Businesses

Table 124. Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 125. Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Hengrui Pharmaceutical Recent Developments

Table 127. Abbott Laboratories Company Information

Table 128. Abbott Laboratories Description and Major Businesses

Table 129. Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 130. Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Abbott Laboratories Recent Developments

Table 132. Fresenius Kabi Company Information

Table 133. Fresenius Kabi Description and Major Businesses

Table 134. Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 135. Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Fresenius Kabi Recent Developments

Table 137. Sandoz Company Information

Table 138. Sandoz Description and Major Businesses

Table 139. Sandoz Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 140. Sandoz Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Sandoz Recent Developments

Table 142. Somerset Therapeutics Company Information

Table 143. Somerset Therapeutics Description and Major Businesses

Table 144. Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 145. Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Somerset Therapeutics Recent Developments

Table 147. Guike Pharmaceutical Company Information

Table 148. Guike Pharmaceutical Description and Major Businesses

Table 149. Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 150. Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. Guike Pharmaceutical Recent Developments

Table 152. Shanghai Pharmaceuticals Company Information

Table 153. Shanghai Pharmaceuticals Description and Major Businesses

Table 154. Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 155. Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

Table 156. Shanghai Pharmaceuticals Recent Developments

Table 157. Themis Medicare Company Information

Table 158. Themis Medicare Description and Major Businesses

Table 159. Themis Medicare Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 160. Themis Medicare Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

Table 161. Themis Medicare Recent Developments

Table 162. Nanjing King-Friend Company Information

Table 163. Nanjing King-Friend Description and Major Businesses

Table 164. Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 165. Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Product Model Numbers, Pictures, Descriptions and Specifications

Table 166. Nanjing King-Friend Recent Developments

Table 167. Key Raw Materials Lists

Table 168. Raw Materials Key Suppliers Lists

Table 169. Neuromuscular Blocking Agent (NMBA) Distributors List

Table 170. Neuromuscular Blocking Agent (NMBA) Customers List

Table 171. Neuromuscular Blocking Agent (NMBA) Market Trends

Table 172. Neuromuscular Blocking Agent (NMBA) Market Drivers

Table 173. Neuromuscular Blocking Agent (NMBA) Market Challenges

Table 174. Neuromuscular Blocking Agent (NMBA) Market Restraints

Table 175. Research Programs/Design for This Report

Table 176. Key Data Information from Secondary Sources

Table 177. Key Data Information from Primary Sources

List of Figures

Figure 1. Neuromuscular Blocking Agent (NMBA) Product Picture

Figure 2. Global Neuromuscular Blocking Agent (NMBA) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Neuromuscular Blocking Agent (NMBA) Market Share by Type in 2023 & 2030

Figure 4. Depolarizing Product Picture

Figure 5. Non-depolarizing Product Picture

Figure 6. Global Neuromuscular Blocking Agent (NMBA) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Neuromuscular Blocking Agent (NMBA) Market Share by Application in 2023 & 2030

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Pharmacy

Figure 11. Others

Figure 12. Neuromuscular Blocking Agent (NMBA) Report Years Considered

Figure 13. Global Neuromuscular Blocking Agent (NMBA) Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Neuromuscular Blocking Agent (NMBA) Revenue 2019-2030 (US$ Million)

Figure 15. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Region (2019-2030)

Figure 17. Global Neuromuscular Blocking Agent (NMBA) Sales 2019-2030 ((MT)

Figure 18. Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Region (2019-2030)

Figure 19. US & Canada Neuromuscular Blocking Agent (NMBA) Sales YoY (2019-2030) & (MT)

Figure 20. US & Canada Neuromuscular Blocking Agent (NMBA) Revenue YoY (2019-2030) & (US$ Million)

Figure 21. Europe Neuromuscular Blocking Agent (NMBA) Sales YoY (2019-2030) & (MT)

Figure 22. Europe Neuromuscular Blocking Agent (NMBA) Revenue YoY (2019-2030) & (US$ Million)

Figure 23. China Neuromuscular Blocking Agent (NMBA) Sales YoY (2019-2030) & (MT)

Figure 24. China Neuromuscular Blocking Agent (NMBA) Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Asia (excluding China) Neuromuscular Blocking Agent (NMBA) Sales YoY (2019-2030) & (MT)

Figure 26. Asia (excluding China) Neuromuscular Blocking Agent (NMBA) Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Sales YoY (2019-2030) & (MT)

Figure 28. Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Revenue YoY (2019-2030) & (US$ Million)

Figure 29. The Neuromuscular Blocking Agent (NMBA) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 30. The Top 5 and 10 Largest Manufacturers of Neuromuscular Blocking Agent (NMBA) in the World: Market Share by Neuromuscular Blocking Agent (NMBA) Revenue in 2023

Figure 31. Global Neuromuscular Blocking Agent (NMBA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 32. Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2019-2030)

Figure 33. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Type (2019-2030)

Figure 34. Global Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2019-2030)

Figure 35. Global Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Application (2019-2030)

Figure 36. US & Canada Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2019-2030)

Figure 37. US & Canada Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Type (2019-2030)

Figure 38. US & Canada Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2019-2030)

Figure 39. US & Canada Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Application (2019-2030)

Figure 40. US & Canada Neuromuscular Blocking Agent (NMBA) Revenue Share by Country (2019-2030)

Figure 41. US & Canada Neuromuscular Blocking Agent (NMBA) Sales Share by Country (2019-2030)

Figure 42. U.S. Neuromuscular Blocking Agent (NMBA) Revenue (2019-2030) & (US$ Million)

Figure 43. Canada Neuromuscular Blocking Agent (NMBA) Revenue (2019-2030) & (US$ Million)

Figure 44. Europe Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2019-2030)

Figure 45. Europe Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Type (2019-2030)

Figure 46. Europe Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2019-2030)

Figure 47. Europe Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Application (2019-2030)

Figure 48. Europe Neuromuscular Blocking Agent (NMBA) Revenue Share by Country (2019-2030)

Figure 49. Europe Neuromuscular Blocking Agent (NMBA) Sales Share by Country (2019-2030)

Figure 50. Germany Neuromuscular Blocking Agent (NMBA) Revenue (2019-2030) & (US$ Million)

Figure 51. France Neuromuscular Blocking Agent (NMBA) Revenue (2019-2030) & (US$ Million)

Figure 52. U.K. Neuromuscular Blocking Agent (NMBA) Revenue (2019-2030) & (US$ Million)

Figure 53. Italy Neuromuscular Blocking Agent (NMBA) Revenue (2019-2030) & (US$ Million)

Figure 54. Russia Neuromuscular Blocking Agent (NMBA) Revenue (2019-2030) & (US$ Million)

Figure 55. China Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2019-2030)

Figure 56. China Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Type (2019-2030)

Figure 57. China Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2019-2030)

Figure 58. China Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Application (2019-2030)

Figure 59. Asia Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2019-2030)

Figure 60. Asia Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Type (2019-2030)

Figure 61. Asia Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2019-2030)

Figure 62. Asia Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Application (2019-2030)

Figure 63. Asia Neuromuscular Blocking Agent (NMBA) Revenue Share by Region (2019-2030)

Figure 64. Asia Neuromuscular Blocking Agent (NMBA) Sales Share by Region (2019-2030)

Figure 65. Japan Neuromuscular Blocking Agent (NMBA) Revenue (2019-2030) & (US$ Million)

Figure 66. South Korea Neuromuscular Blocking Agent (NMBA) Revenue (2019-2030) & (US$ Million)

Figure 67. China Taiwan Neuromuscular Blocking Agent (NMBA) Revenue (2019-2030) & (US$ Million)

Figure 68. Southeast Asia Neuromuscular Blocking Agent (NMBA) Revenue (2019-2030) & (US$ Million)

Figure 69. India Neuromuscular Blocking Agent (NMBA) Revenue (2019-2030) & (US$ Million)

Figure 70. Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Sales Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Type (2019-2030)

Figure 72. Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Sales Market Share by Application (2019-2030)

Figure 73. Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Revenue Market Share by Application (2019-2030)

Figure 74. Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Revenue Share by Country (2019-2030)

Figure 75. Middle East, Africa and Latin America Neuromuscular Blocking Agent (NMBA) Sales Share by Country (2019-2030)

Figure 76. Brazil Neuromuscular Blocking Agent (NMBA) Revenue (2019-2030) & (US$ Million)

Figure 77. Mexico Neuromuscular Blocking Agent (NMBA) Revenue (2019-2030) & (US$ Million)

Figure 78. Turkey Neuromuscular Blocking Agent (NMBA) Revenue (2019-2030) & (US$ Million)

Figure 79. Israel Neuromuscular Blocking Agent (NMBA) Revenue (2019-2030) & (US$ Million)

Figure 80. GCC Countries Neuromuscular Blocking Agent (NMBA) Revenue (2019-2030) & (US$ Million)

Figure 81. Neuromuscular Blocking Agent (NMBA) Value Chain

Figure 82. Neuromuscular Blocking Agent (NMBA) Production Process

Figure 83. Channels of Distribution

Figure 84. Distributors Profiles

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Neuromuscular Blocking Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Skeletal Muscular Relaxants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Quantitative Neuromuscular Transmission Monitor Market Research Report 2025

Global Muscle Relaxant Monitor Market Research Report 2024

Global Safety Block Market Research Report 2025

Global Metal Blocker Market Research Report 2025

Nozzle Anti blocking Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Dual Channel Neuromuscular Electrical Stimulation Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Handheld Neuromuscular Electrical Stimulator Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Glutamate Receptor Ionotropic NMDA 2B Market Research Report 2025

Global DC Blocker Market Research Report 2024

Global Intramuscular Drug Delivery Market

Global Antiblock Agents Market Research Report 2024

Global Pancuronium Bromide Market Research Report 2024

Global Antibody Interference Blockers Market Insights Forecast to 2030

Global Automatic Ophthalmic Lens Blocker Market Research Report 2025

Global Gamma Aminobutyric Acid Market Research Report 2024

Global Rocuronium Bromide Market Research Report 2024

Global Glutamate Antagonist Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions